IDiyas

For the Inventor, By the Inventor

La Jolla, CA, United States of America

Orexigen Therapeutics, Inc.


USPTO Granted Patents = 17



Trademarks = 5

Forward Citations = 322

Loading Chart...
Loading Chart...

21 inventors (with patents filed for the assignee):

goldMedal Gary Dennis Tollefson (9 out of 20 patents)

silverMedal Anthony A McKinney (8 out of 10 patents)

bronzeMedal Eckard Weber (6 out of 70 patents)

4.  Michael Alexander Cowley (4 out of 10 patents)

5.  Preston Klassen (4 out of 11 patents)

6.  Kristin Taylor (4 out of 15 patents)

7.  Rick Soltero (4 out of 5 patents)

8.  Richard Soltero (2 out of 13 patents)

9.  Thea Elise Dunzo (2 out of 2 patents)

10.  K Ranga R Krishnan (2 out of 6 patents)

11.  Kishore M Gadde (2 out of 5 patents)

12.  Eduardo Dunayevich (1 out of 5 patents)

13.  Shawn Flanagan (0 patent)

14.  Susan McElroy (0 patent)

15.  Ron Landbloom (0 patent)


17 patents:

1. 9801875 - Compositions and methods for weight loss in at risk patient populations (2017-10-31),
2. 9633575 - Methods of treating overweight and obesity (2017-04-25),
3. 9457005 - Compositions and methods for increasing insulin sensitivity (2016-10-04),
4. 9248123 - Methods of providing weight loss therapy in patients with major depression (2016-02-02),
5. 9125868 - Methods for administering weight loss medications (2015-09-08),
6. 9119850 - Compositions and methods for weight loss in at risk patient populations (2015-09-01),
7. 9107837 - Sustained release formulation of naltrexone (2015-08-18),
8. 8969371 - Compositions and methods for weight loss in at risk patient populations (2015-03-03),
9. 8916195 - Sustained release formulation of naltrexone (2014-12-23),
10. 8815889 - Compositions and methods for increasing insulin sensitivity (2014-08-26),
11. 8722085 - Methods for administering weight loss medications (2014-05-13),
12. 8318788 - Layered pharmaceutical formulations (2012-11-27),
13. 8088786 - Layered pharmaceutical formulations (2012-01-03),
14. 7462626 - Compositions for affecting weight loss (2008-12-09),
15. 7429580 - Compositions of an anticonvulsant and an antipsychotic drug and methods of using the same for affecting weight loss (2008-09-30),
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of obesity. They are committed to helping patients achieve significant and sustained weight loss through their proprietary drug formulations. Orexigen's extensive research and development efforts aim to address the global obesity epidemic and improve the lives of millions of people suffering from obesity-related health conditions.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

17 Patents

#32 in La Jolla, CA

#4,369 in California

#18,253 in US

#34,802 in the World

...
La Jolla, CA, United States of America

Orexigen Therapeutics, Inc.

Forward Citations = 322

21 inventors:

goldMedal Gary Dennis Tollefson (9 out of 20 patents)

silverMedal Anthony A McKinney (8 out of 10 patents)

bronzeMedal Eckard Weber (6 out of 70 patents)

4.  Michael Alexander Cowley (4 out of 10 patents)

5.  Preston Klassen (4 out of 11 patents)

Please report any incorrect information to support@idiyas.com
Loading…